EANS-News: AGENNIX AG / Agennix AG Raises Approximately EUR 76 Million in Net Proceeds in Capital Increase
Further inquiry note: Investor Relations & Corporate Communications Tel.: +49 (0) 89 8565 2693 E-Mail: ir@agennix.com Branche: Pharmaceuticals ISIN: DE000A1A6XX4 WKN: A1A6XX Index: CDAX, Prime All Share, Technology All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Hamburg / free ...